Drug intelligence / Profile preview

codeine + promethazine

Development stage
Approved
Lead developer
Sanofi
Modality
Small Molecules
Administration
Oral
01

Overview

**Codeine + promethazine** is a combination drug commonly used in oral syrup or solution form for the temporary relief of cough and upper respiratory symptoms associated with allergies or the common cold[1][5][6]. **Promethazine** is a first-generation antihistamine of the phenothiazine class that works by blocking H1 histamine receptors, reducing symptoms like sneezing, runny nose, and congestion. It also has antidopaminergic, anticholinergic, and sedative properties. **Codeine** is a natural opioid that acts as an agonist at mu-opioid receptors in the central nervous system, suppressing the cough reflex and providing mild analgesic effects[1][3][12]. The combination is indicated for adults and not recommended for children under 18 due to risk of respiratory depression and other serious adverse events[6]. This product is available only by prescription.

Brand names
Phenergan with Codeine
Other names
promethazine and codeinepromethazine/codeinepromethazine + codeine
02

Targets

MOR (Mu opioid receptor)HRH1 (Histamine H1 Receptor)ADRA1A (α1A)mAChR (Muscarinic acetylcholine receptors)DRD2 (Dopamine D2 Receptor)NMDAR (Glutamate receptor ionotropic, NMDA)

Beyond the preview

Go deeper on codeine + promethazine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on codeine + promethazine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call